These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 23540586)
1. Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease. Hardy RS; Seibel MJ; Cooper MS Curr Opin Pharmacol; 2013 Jun; 13(3):440-4. PubMed ID: 23540586 [TBL] [Abstract][Full Text] [Related]
2. 11beta-Hydroxysteroid dehydrogenase: a regulator of glucocorticoid response in osteoporosis. Cooper MS J Endocrinol Invest; 2008 Jul; 31(7 Suppl):16-21. PubMed ID: 18791346 [TBL] [Abstract][Full Text] [Related]
3. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes. Morgan SA; Tomlinson JW Expert Opin Investig Drugs; 2010 Sep; 19(9):1067-76. PubMed ID: 20707593 [TBL] [Abstract][Full Text] [Related]
4. Type 1 11beta-hydroxysteroid dehydrogenase as universal drug target in metabolic diseases? Oppermann U Endocr Metab Immune Disord Drug Targets; 2006 Sep; 6(3):259-69. PubMed ID: 17017977 [TBL] [Abstract][Full Text] [Related]
5. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Walker BR Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Stimson RH; Walker BR Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid metabolism in rheumatoid arthritis. Hardy RS; Raza K; Cooper MS Ann N Y Acad Sci; 2014 May; 1318():18-26. PubMed ID: 24579884 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Wang M Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570 [TBL] [Abstract][Full Text] [Related]
10. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice. Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962 [TBL] [Abstract][Full Text] [Related]
11. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation. Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379 [TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis. Ramli ES; Suhaimi F; Asri SF; Ahmad F; Soelaiman IN J Bone Miner Metab; 2013 May; 31(3):262-73. PubMed ID: 23274351 [TBL] [Abstract][Full Text] [Related]
13. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. Cooper MS; Bujalska I; Rabbitt E; Walker EA; Bland R; Sheppard MC; Hewison M; Stewart PM J Bone Miner Res; 2001 Jun; 16(6):1037-44. PubMed ID: 11393780 [TBL] [Abstract][Full Text] [Related]
14. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons. Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218 [TBL] [Abstract][Full Text] [Related]
15. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type. Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798 [TBL] [Abstract][Full Text] [Related]
16. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue. Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364 [TBL] [Abstract][Full Text] [Related]
17. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Seckl JR; Walker BR Endocrinology; 2001 Apr; 142(4):1371-6. PubMed ID: 11250914 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Stewart PM; Toogood AA; Tomlinson JW Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677 [TBL] [Abstract][Full Text] [Related]
19. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells. Nigawara T; Iwasaki Y; Asai M; Yoshida M; Kambayashi M; Sashinami H; Hashimoto K; Suda T Endocrinology; 2006 Feb; 147(2):769-72. PubMed ID: 16254034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]